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Cyclosporin A is an immunosuppressant drug widely used in
solid organ transplantation, but it has nephrotoxic properties
that promote oxidative stress. The JAK2/STAT pathway has
been implicated in both cell protection and cell injury;
therefore, we determined a role of JAK2 in oxidative stress-
mediated renal cell injury using pathophysiologically relevant
oxidative challenges. The AG490 JAK2 inhibitor and
overexpression of a dominant negative JAK2 protein
protected endothelial and renal epithelial cells in culture
against peroxide, superoxide anion and cyclosporin A
induced cell death while reducing intracellular oxidation in
cells challenged with peroxide and cyclosporin A. The
decrease in Bcl2 expression and caspase 3 activation, induced
by oxidative stress, was prevented by AG490. In mouse
models of ischemia/reperfusion and cyclosporin A
nephrotoxicity, AG490 decreased peritubular capillary and
tubular cell injury. Our study shows that JAK2 inhibition is a
promising renoprotective strategy defending endothelial and
tubular cells from cyclosporin A- and oxidative stress-induced
death.
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End-stage renal disease requiring chronic dialysis occurs in
up to 20% of nonrenal transplant recipients, being the use of
calcineurin inhibitors a risk factor.1 The immunosuppressive
drug cyclosporin A (CsA) is a calcineurin inhibitor that
causes acute kidney injury as well as a chronic tubulointer-
stitial nephropathy. Reactive oxygen species (ROS) are
important mediators of CsA-induced cell injury and they
are increased in failing transplanted kidneys from patients
treated with CsA.2–4 ROS participate in other forms of acute
and chronic renal injury such as that caused by ischemia/
reperfusion (I/R).5–7
The Janus kinase/signal transducers and activators of
transcription (JAK/STAT) pathway may be activated by
ligand binding to cytokine receptors as well as by cellular
stress induced by I/R, ROS, endotoxin, or hyperosmolar-
ity.8–10 Signaling through the canonical JAK/STAT pathway
has been extensively characterized in immune cells. In fact,
the JAK2 inhibitor AG490 interferes with lymphocyte
activation and prevents transplant rejection.11,12
Both pro- and antiapoptotic actions have been ascribed to
JAK2 tyrosine kinase activity in a variety of signaling
systems.13–18 The factors that determine these different
outcomes are poorly understood. Cell type- or stimulus-
specific factors may have a role.
JAK2 inhibition increases resistance to H2O2-induced
apoptosis of vascular smooth muscle cells.13 By contrast,
JAK2/STAT is required for endothelial cell and cardiomyocyte
survival in response to granulocyte colony-stimulating factor
after myocardial infarction.18 More recently, two studies have
related JAK2 to tubular cell injury, but its role in
nephrotoxicity has not been addressed.19,20
The JAK2 inhibitor AG490 protects cultured endothelial
cells (EC) from cell death pathways involving oxidative stress
activated by serum deprivation or detachment.21–23 Oxidative
stress is also important in injury of EC and renal proximal
tubular epithelial cells (PTECs) in the course of CsA
nephrotoxicity and I/R.3,4,24,25 The aim of the present study
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has been to examine the hypothesis that JAK2 inhibition
protects EC and PTEC from different forms of oxidative
stress, including that induced by CsA, and to analyze the
mechanisms involved. Cell culture data were coupled with
in vivo validation of the therapeutic potential of JAK2
inhibition in nephrotoxic and I/R renal injury.
RESULTS
JAK2 inhibition protects endothelial cells and proximal
tubular epithelial cells from oxidative stress
The effect of JAK2 inhibition on cell death was examined in
cells cultured for 24 h with stimuli causing oxidative stress.
The JAK2 inhibitor AG490 prevented H2O2-induced death of
bovine aorta endothelial cells (BAECs), even at high H2O2
concentrations (250 mmol/l–1 mmol/l) (Figure 1a). Similar
protection was observed in human umbilical vein endothelial
cells (HUVECs) (Figure 1b). In addition, PTECs were also
significantly protected from H2O2-induced injury by AG490
(Figure 1c).
AG490 also prevented cell death induced by superoxide
anion generated by the hypoxanthine/xanthine oxidase
(HX/XO) system in BAEC (Figure 2a) and PTEC
(Figure 2b).
The use of a pharmacologic inhibitor, such as AG490,
raises the issue of specificity. In an additional set of
experiments overexpression of a dominant-negative JAK2
(JAK2-DN) significantly blocked cell death induced by H2O2
in both BAEC and PTEC (Figure 2c and d). This result
confirmed that JAK2 inhibition was a key factor in the
cytoprotection offered by AG490. As a specificity control,
AG82, a structurally similar, non-JAK2-blocking tyrphostin
analogue, was not protective (data not shown).
Additional experiments were performed to clarify the
mechanisms involved in protection by AG490, focusing in
apoptotic events. AG490 prevented the decrease in Bcl2 levels
induced by H2O2 in BAEC (Figure 3a). As the levels of Bax in
the same samples were constant, the Bcl2/Bax ratio was
significantly increased by AG490 (Figure 3a; Po0.01). In
addition AG490 significantly decreased H2O2-induced cas-
pase 3 activity (Figure 3b). Studies in PTEC yielded similar
results (n¼ 3, data not shown).
AG490 significantly inhibited BAEC death induced by the
oxidant stress-generating nephrotoxin CsA (Figure 4a).
Similar results were obtained by overexpressing a JAK2-DN
protein (data not shown), therefore confirming the role of
JAK2. AG490 also protected PTEC from CsA toxicity (Figure
4b).
As expected from inhibitor studies, H2O2 and CsA
induced JAK2 and STAT3 phosphorylation, indicating
activation, in BAEC (Figure 4c) and PTEC (Figure 4d). In
both cell types AG490 inhibited JAK2 phosphorylation
induced by H2O2 or CsA (Figure 4c and d).
Antioxidant effects of JAK2 inhibition
This experiment was designed to elucidate whether AG490
protects from the consequences of oxidative stress or reduces
the generation of ROS. AG490 decreased baseline oxidation
of dihydrorhodamine to fluorescent rhodamine (Figure 5a
and b). Furthermore, AG490 prevented the increase in
rhodamine fluorescence induced by H2O2 in BAEC and
PTEC (Figure 5a and b). These results suggest that AG490
possesses significant antioxidant properties in both cell types.
In BAEC overexpression of JAK2-DN also decreased
rhodamine fluorescence in response to H2O2 (Figure 5c),
supporting the hypothesis that JAK2 inhibition is responsible
for the antioxidant effect.
As expected, CsA also increased the generation of ROS in
BAEC and PTEC. This was also markedly inhibited by AG490
(Figure 5a and b).
Superoxide anion production was assessed by the genera-
tion of ethidium from dihydroethidium. AG490 significantly
reduced ethidium red fluorescence, indicative of superoxide
anion production, in BAEC and PTEC under basal
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Figure 1 | JAK2/STAT pathway inhibition with AG490 protects
from H2O2-induced cell death. Cells were treated with 50 mmol/l
AG490 or vehicle (0.1% DMSO) before exposure to H2O2 for 24 h.
(a) AG490 protects bovine aorta endothelial cells (BAECs) from
H2O2-induced cell death (n¼ 6, *Po0.05 with respect to vehicle-
treated cells; **Po0.001 with respect to vehicle-treated cells). (b)
AG490 protects human umbilical vein endothelial cells (HUVECs)
from H2O2 (n¼ 4, *Po0.05 with respect to vehicle-treated cells).
(c) AG490 protects proximal tubular epithelial cells (PTECs) from
H2O2 (n¼ 5, *Po0.05 with respect to vehicle-treated cells). Cell
death was assayed by an LDH release assay.
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conditions or following stimulation with H2O2 or CsA
(Figure 6a and b).
In vivo mouse models
The in vivo relevance of the cell culture results was evaluated
in a previously described mouse model of CsA nephrotoxi-
city.3 CsA induced severe histological kidney tubular injury
(Figure 7b and e) which was significantly attenuated by
AG490 (Figure 7c and f) (histological injury score 3.9±0.8 vs
1.6±0.7, Po0.01). In addition CsA-induced capillary
endothelial injury, assessed as increased lectin staining, which
was also reduced by AG490 (Figure 7g–i). Oxidative stress was
estimated by malondialdehyde (MDA) staining. Increased
MDA in CsA-treated kidneys, indicating oxidative stress
(Figure 7k), was significantly reduced by AG490 (Figure 7l).
An I/R mice model was also studied. Mice were injected
with AG490 or its vehicle (dimethyl sulfoxide, DMSO) before
30 min of bilateral ischemia followed by 24 h of reperfusion.
Bilateral I/R caused renal failure (serum creatinine:
sham-operated mice: 0.30±0.05 mg/100 ml; DMSO:
0.56±0.13 mg/100 ml), which was prevented by AG490
(AG490: 0.31±0.09 mg/100 ml, *Po0.05 vs DMSO-treated
mice). I/R also induced histological kidney tubular injury
(Figure 8b and e), characterized by detached epithelium and
leukocyte infiltration. This injury was significantly attenuated
in the AG490 group (Figure 8c and f).
Endothelial injury, assayed by lectin binding, was
significantly increased in DMSO kidneys and prevented by
AG490 (Figure 8h and i). Finally, increased MDA in DMSO
kidneys (Figure 8k), was significantly reduced under AG490
pretreatment (Figure 8l).
DISCUSSION
Oxidative stress is a major factor contributing to different
forms of kidney injury, including I/R and nephrotoxicity.
Our results provide evidence of the potent endothelial and
tubular cytoprotective effect of JAK2 pathway inhibition by
AG490. AG490 cytoprotection was observed in different
forms of pathophysiologically relevant oxidative challenges,
such as H2O2, superoxide, and the nephrotoxic drug CsA.
Indeed for the first time it is demonstrated that JAK2
activation is a common injurious mechanism shared by EC
and PTEC, two of the main targets of CsA toxicity and that
JAK2 contributes to enhance oxidative stress. Potential
applications of these findings include acute kidney injury
and kidney transplantation. In both circumstances oxidative
stress-mediated damage to the two cellular types examined
here is prominent.26,27
The function of AG490 as a JAK2 inhibitor is supported by
the literature9,28,29 as well as by our results showing that it
prevents JAK2 activation in cells stimulated with H2O2 or
CsA. In addition the beneficial effects of AG490 were
reproduced by JAK2-DN, but not by a structurally similar
tyrphostin.21
Our results showing that different forms of oxidative stress
activate JAK2 and induce JAK2-mediated cell death support
the notion that JAK2 should be considered an oxidative
stress-activated kinase.9,28–30 Furthermore, our results sup-
port other evidence13,28 indicating that in oxidative stress the
JAK2 pathway has an injurious role, at least in two key targets
of kidney injury: the endothelium and tubular cells.
In addition, our data suggest that AG490 has a JAK2-
dependent antioxidative effect, as both JAK2-DN and AG490
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Figure 2 | JAK2/STAT pathway inhibition with AG490 protects from superoxide-induced cell death and a dominant-negative form of
JAK2 (JAK2-DN) protects from oxidative stress-induced cell death. (a) AG490 protects BAEC from XO/HX-induced death (n¼ 3; *Po0.05
with respect to vehicle-treated cells; **Po0.001 with respect to vehicle-treated cells). (b) AG490 also protects PTEC from XO/HX (n¼ 3;
*Po0.05 with respect to vehicle-treated cells). (c) JAK2-DN protects BAEC from cell death induced by 250 mmol/l H2O2 (n¼ 3; *Po0.05 with
respect to the baseline). (d) JAK2-DN protects PTEC from cell death induced by 1 mmol/l H2O2 (n¼ 3; *Po0.02 with respect to the baseline).
Cell death was assayed by an LDH release assay.
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decreased oxidative stress. These results are, to the best of our
knowledge, novel, differ from those recently reported in glial
cells, where JAK2-independent antioxidant properties of
AG490 were described28,31 and could point to cell-specific
differences. One step beyond, our data suggest that JAK2 is a
central regulator of oxidative stress-mediated cell injury: it is
activated by oxidative stress, and, in turn, promotes oxidative
stress. A contribution of oxidant scavenger properties of
AG490 cannot be ruled out a priori, but this possibility is not
supported by its chemical structure.32
AG490 prevented the decreased expression of antiapopto-
tic proteins, such as Bcl2, induced by oxidative stress. The
Bcl2/Bax ratio represents the balance between cellular anti- vs
proapoptotic proteins.33,34 In addition AG490 prevented
executioner caspase activation. These results are in agreement
with the ability of ROS and CsA to induce apoptosis in
endothelial and tubular cells.3
The central role of JAK2 in oxidative stress-mediated cell
injury suggests that JAK2 inhibition may be of particular
interest in diseases characterized by oxidative stress such as
nephrotoxic and I/R acute kidney injury.35,36 Indeed,
beneficial effects of AG490 were confirmed in vivo, both in
tubular cells and peritubular capillaries, suggesting poten-
tially practical applications.
We demonstrate for the first time JAK2 activation by CsA.
Of outstanding interest, the findings concerning peritubular
capillaries are in agreement with previous studies showing
that CsA injures these particular vessels, but not the
glomeruli.37 The increase in lectin binding is indicative of
expression of neomarkers by injured endothelium.38,39
However, this pattern had not been previously described in
CsA nephrotoxicity. AG490 strongly protected these capil-
laries against CsA, a result with potential interest in
prevention of microcirculatory injury by calcineurin inhibi-
tors, as damage to the microcirculation is critical for both
acute and chronic CsA-related injury.37,40
Two previous studies have pioneered, one in cell culture
and one in vivo, the study of JAK2 as a therapeutic target in
tubular cell injury.19,20 We now identify different cell targets
of the cytoprotective effect of JAK2 inhibition (not only
tubular but also endothelial cells), confirm the role of JAK2
by means of a dominant-negative protein, identify a
particular stimulus of clinical significance (CsA) which
promotes JAK2-dependent tubular and endothelial injury,
define the role of JAK2 as a promoter of oxidative stress and
extend the cell culture observations to in vivo models.
Collectively, the present results reveal that JAK2 is a key
factor for the development of H2O2-, superoxide-, and CsA-
induced cell death in EC and PTEC. AG490 is nephro-
protective by inhibiting JAK2 activation by oxidative stress
and JAK2-induced oxidative stress in tubular and endothelial
cells. Potential applications of JAK2 inhibition include acute
kidney injury of nephrotoxic or ischemic nature, or a
combination of both, as may occur in the immediate post-
transplant period. Their potential to suppress solid organ
graft rejection further adds to their appeal.11,12
MATERIALS AND METHODS
Cell culture
BAECs, HUVECs, and pig PTECs were obtained, characterized, and
cultured as described,6,41,42 and used only as primary cultures
(passages 2–6). EC and PTEC were the principal experimental source
and HUVEC were employed only for confirmatory studies. Written
informed consent was obtained for the use of umbilical cords. All
procedures on animals, including sampling, were performed
according to the International regulatory standards and the
Institutional Research Committee rules.
In vivo studies
A previously characterized model of CsA nephrotoxicity was
studied.3 Adult male C57Bl/6 mice (9 to 12-week old, 35–40 g;
Harlan Interfauna, Madrid, Spain) were divided in four groups
(n¼ 6 each): control (DMSO vehicle-treated), AG490 (1.5 mg/kg/
day, i.p.), CsA (250 mg/kg/day, s.c.), and CsAþAG490. It should be
emphasized that the dose of CsA required to induce toxicity in mice
is higher than in humans. Vehicle (DMSO) or AG490 were
administered daily 1 h before CsA. Mice were killed by anesthetic
overdose after 5 days of treatment and kidneys were perfused with
Ringer lactate and included in paraffin for hematoxylin/eosin
staining and immunohistochemistry.
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Figure 3 | AG490 preserves Bcl2 expression and prevents
caspase-3 activation induced by H2O2 in BAEC. (a) Western
blot. Cells were incubated for 1 h with vehicle or 50 mmol/l AG490,
in the absence or presence of 250 mmol/l H2O2. a-Tubulin was
used as loading control. The Bcl2/Bax ratio was determined by
band intensity quantitation (*Po0.01 with respect to the other
conditions, n¼ 4). (b) Caspase 3 activity was measured as
processing of the fluorogenic substrate Ac-DEVD-AMC. Cells were
incubated for 24 h with vehicle or 50 mmol/l AG490, in the absence
or presence of 250 mmol/l H2O2. Results are expressed as %
change over vehicle control in the absence of H2O2 (n¼ 3,
*Po0.01 with respect to all the other conditions).
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A similar protocol was applied to a model of I/R. Three groups of
mice were studied: (1) sham-operated mice (n¼ 4); (2) I/R with
vehicle (DMSO) 1 h before 30 min of bilateral renal artery clamping
(n¼ 4); (3) I/RþAG490 (n¼ 4). Animals were killed 24 h after
surgery by anesthetic overdose.
For Bandeiraea simplicifolia BS-I peroxidase-conjugated lectin
(Sigma-Aldrich, Madrid, Spain) binding to peritubular capillaries
studies, kidney sections were incubated overnight (4 1C) with lectin
(12.5mg/ml) in phosphate-buffered salineþ 0.1 mmol/l CaCl2,
MgCl2, MnCl2þ 0.1% Triton X-100, developed with 3030-diamino-
benzidine and counterstained with hematoxylin. Peritubular capil-
lary and tubular injury was scored by two independent observers,
who were blinded for sample’s identity. Peritubular capillary damage
was estimated according to the intensity of the lectin signal, on a 41
color intensity scale. A previously published score was use for
tubular damage.3 Oxidative stress was assessed by immunohisto-
chemical staining for MDA, a product of lipid peroxidation. After
heat retrieval paraffin sections were incubated overnight (4 1C)
with rabbit polyclonal anti-MDA (Abcam, Cambridge, UK) (1/500
in Tris-buffered saline), and HRP-conjugated secondary antibody
(1/200 in Tris-buffered saline).
Cell challenge
Confluent EC or PTEC were exposed to H2O2 (Sigma-Aldrich)
(100–1000mmol/l), HX/XO (Sigma-Aldrich) (2 mmol/l, 5 mU/ml),
or CsA (10–25 mmol/l, Sigma-Aldrich). Different concentrations
were used for BAEC or PTEC depending on cell sensibility. Vehicle
(DMSOo0.1%) or the specific JAK2 inhibitor AG490 (Calbiochem,
Nottingham, UK)13,28,29 were added 45 min before the experimental
maneuvers. Dose–response experiments disclosed that 10mmol/l
AG490 significantly (Po0.05) protected from 250mmol/l H2O2-
induced EC death and that 50 mmol/l AG490 offered complete
protection. Thus 50 mmol/l AG490 was used for further experiments.
EC and PTEC were transfected with a JAK2-DN expression
plasmid using Fugene in nearly confluent (80–90%) cells. The
optimal transfection was achieved at Fugene–DNA ratio of
30 ml–10 mg in 6 ml of serum-free media for 6 h. Then FBS was
added to reach usual growth media concentration. Cells were
allowed to grow for 24 h, trypsinized and seeded onto 96-well plates
or glass cover slips. Transfection efficiency was evaluated using
pEGFP-N1 vector (BD Transduction Laboratories, San Jose, CA,
USA), and was more than 50% in all cases. Wild-type JAK2 (pBOS-
HAJAK2) and a kinase domain mutant of JAK2 (pBOS-HAdkJAK2)
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Figure 4 | AG490 protects BAEC and PTEC from cyclosporin A (CsA)-induced death. (a) AG490 protects BAEC from death induced
by 10mmol/l CsA, as assayed by LDH release at 24 h (n¼ 4, *Po0.05 with respect to vehicle-treated cells; **Po0.01 with respect to
vehicle-treated cells). (b) Cytoprotective effect of 50 mmol/l AG490 against 25mmol/l CsA in PTEC, as assayed by LDH release at 24 h
(n¼ 3, *Po0.01 vs vehicle-treated cells). (c) Western blot analysis of JAK2 and STAT3 phosphorylation profile in BAEC activated by H2O2 or
CsA. (d) Western blot analysis of JAK2 and STAT3 phosphorylation profile in PTEC activated by H2O2 or CsA. Total JAK2 and STAT3 were used
as loading controls. Values represent phospho-JAK2 and phospho-STAT3 relative band intensity with respect to total JAK2 and STAT3,
expressed as fold-change over time¼ 0 min. Blots on the right show inhibition of JAK2 and STAT3 phosphorylation by AG490, assayed a
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condition. The experiments shown are representative of 3 with identical results.
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which has dominant-negative activity (a gift from Dr Dwayne L
Barber, Ontario Cancer Institute, Toronto, Canada) were used. In all
cases, an empty vector was employed as control.
Cell damage following stimulation with H2O2 or CsA for 24 h
was assessed by lactate dehydrogenase (LDH) release, using a
commercial kit (Cytotox 96 Non-radioactive Cytotoxicity Assay,
Promega, Madrid, Spain).
Western blot
For western blot 40mg protein was loaded. Blots were reprobed with
anti-a-tubulin to account for minor differences in loading.21,43,44
Antibodies. Rabbit polyclonal anti-JAK2, rabbit polyclonal
anti-(Tyr1007/1008)-phospho-JAK2, rabbit polyclonal anti-
(Tyr705)-phospho-STAT3, rabbit polyclonal anti-STAT3 (Cell Sig-
naling, Beverly, MA, USA), rabbit polyclonal anti-Bax (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA), mouse monoclonal anti-
a-tubulin (Sigma-Aldrich), and mouse monoclonal anti-Bcl-2 (BD
Transduction Laboratories).
Caspase 3 activity
Caspase 3 activity was assessed in confluent cells following
incubation with the stimuli for 24 h. Cells were lysed with
20 mmol/l EDTA, 0.5% Triton X-100, and 5 mmol/l Tris-HCl
pH¼ 8. Lysates were exposed to protease assay buffer (60 mmol/l
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid pH 7.5, 30%
glycerol, and 4 mmol/l dithiothreitol) with caspase 3 fluorogenic
substrate Ac-DEVD-AMC (BD Transduction Laboratories). Activity
was expressed as light signal at 380/440 nm exciting/emission
wavelength.
Measurement of intracellular ROS
The cell-permeable fluorogenic probe, dihydrorhodamine 123, was
used for the detection of intracellular ROS.45,46 AG490 was added
45 min before H2O2 or CsA. EC or PTEC grown on glass cover slips
were incubated with dihydrorhodamine 123 (15 min, 37 1C,
10 mmol/l DHR123; Molecular Probes, Eugene, OR, USA), washed
with phosphate-buffered saline (2 ) and fixed with Merckofix
(Merck, Darmstadt, Germany). H2O2 or CsA were used at 10 or
100 mmol/l, respectively, to avoid fluorescence saturation. Confocal
fluorescence images were obtained with a Confocal System TCS
SP20 (Leica, Madrid, Spain). Photographs of triplicate experiments,
repeated at least four times, were taken using identical exposure
conditions and quantified by the ImageJ software (NIH, Bethesda,
MD, USA).
For superoxide anion detection, 10 mmol/l dihydroethidium
(Calbiochem) was added for the last 15 min of the experiment
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Figure 5 | AG490 or dominant-negative JAK2 (JAK2-DN)
reduce oxidative stress in response to H2O2 or CsA. Confocal
microphotographs of rhodamine 123 fluorescence: (a) confluent
BAEC grown on glass cover slips were treated with 100mmol/l
H2O2 or 10mmol/l CsA for 1 h in the presence of AG490 or vehicle
and incubated for the last 15 min with dihydrorhodamine 123.
*Po0.01 vs its respective vehicle-treated control. (b) Similar
results were obtained in PTEC treated with 100mmol/l H2O2 or
10mmol/l CsA for 1 h. *Po0.01 vs its respective vehicle-treated
control. (c) JAK2-DN overexpression decreased the rhodamine
signal in transfected BAEC exposed to H2O2. Images were taken
with identical exposure conditions. Photographs are
representative of three different experiments yielding similar
results. *Po0.05 vs empty vector; **Po0.05 vs H2O2-treated cells.
Relative red fluorescence was quantified and expressed as fold-
change±s.d. over cells treated with vehicle or empty vector
(n¼ 4).
0.65±0.19*
0.60±0.21*
0.22±0.10*1.00±0.140.43±0.14*1.00±0.21
1.88±0.250.92±0.111.10±0.17
1.44±0.301.15±0.26*2.01±0.36
CsA CsA + AG490 CsA CsA + AG490
H2O2 H2O2H2O2 + AG490 H2O2 + AG490
CM AG490 CM AG490
PTECBAEC
Figure 6 | AG490 decreases superoxide anion production in
response to H2O2 or CsA. Microphotographs of ethidium
fluorescence. (a) Confluent BAEC grown on glass cover slips were
treated with 100 mmol/l H2O2 or 10mmol/l CsA for 1 h in the
presence of AG490 or vehicle and incubated for the last 15 min
with dihydroethidium. (b) Similar results were obtained in PTEC
treated with 100 mmol/l H2O2 or 10mmol/l CsA for 1 h. Images
were taken with identical exposure conditions and gray-scaled.
Photographs are representative of three different experiments
yielding similar results. Numbers indicate relative red fluorescent
quantification, expressed as mean fold-change±s.d. over cells
treated with vehicle (n¼ 3). *Po0.05 vs its respective vehicle-
treated control.
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and its oxidized fluorescent form ethidium was detected by confocal
microscopy.43
Statistics
Results are expressed as mean±s.e.m. Unless stated otherwise, each
value of in vitro experiments corresponds to a minimum of four
triplicate studies. Comparisons were performed by analysis of
variance, paired or unpaired Student’s t-test, when appropriate.
Fisher’s and Scheffe’s tests for multiple comparisons were used to
determine the P-value, which was considered significant at o0.05.
The statistic analysis was performed with Windows SPSS 10.0
package (SPSS Inc., Chicago, IL, USA). Densitometry analysis and
image quantification was performed using ImageJ software (NIH).
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